Incomplete systemic capillary leak syndrome after COVID-19 vaccination: a case-based review.

IF 1.6 4区 医学 Q4 IMMUNOLOGY
Central European Journal of Immunology Pub Date : 2025-01-01 Epub Date: 2025-05-05 DOI:10.5114/ceji.2025.149254
Jaroslaw Nowakowski, Brygida Marczyk, Joanna Przeniosło, Zuzanna Sawiec, Kinga Żmuda, Mariusz Korkosz
{"title":"Incomplete systemic capillary leak syndrome after COVID-19 vaccination: a case-based review.","authors":"Jaroslaw Nowakowski, Brygida Marczyk, Joanna Przeniosło, Zuzanna Sawiec, Kinga Żmuda, Mariusz Korkosz","doi":"10.5114/ceji.2025.149254","DOIUrl":null,"url":null,"abstract":"<p><p>Although generalized edema is a rare adverse event after drugs or vaccinations, here we report a case of generalized edema with systemic inflammatory reaction clinically similar to incomplete systemic capillary leak syndrome (SCLS), potentially triggered by COVID-19 immunization. The patient presented with generalized subcutaneous edema, a drop in blood pressure, elevated inflammatory biomarkers, and hypoalbuminemia after receiving the vaccine, with no other apparent cause than vaccination. Comprehensive diagnostic evaluation revealed no specific underlying cause. She was treated with glucocorticosteroids successfully. This case underscores the importance of recognizing rare but severe adverse events associated with vaccinations. Given the widespread administration of COVID-19 vaccines, it is crucial to identify and understand such reactions to ensure timely diagnosis and management. Therefore, we review the existing cases of SCLS following COVID-19 vaccination. Our review highlights the need for heightened vigilance and further research into the mechanisms underlying vaccine-induced phenomena to improve patient outcomes and vaccine safety profiles.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"50 1","pages":"119-121"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224252/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/ceji.2025.149254","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Although generalized edema is a rare adverse event after drugs or vaccinations, here we report a case of generalized edema with systemic inflammatory reaction clinically similar to incomplete systemic capillary leak syndrome (SCLS), potentially triggered by COVID-19 immunization. The patient presented with generalized subcutaneous edema, a drop in blood pressure, elevated inflammatory biomarkers, and hypoalbuminemia after receiving the vaccine, with no other apparent cause than vaccination. Comprehensive diagnostic evaluation revealed no specific underlying cause. She was treated with glucocorticosteroids successfully. This case underscores the importance of recognizing rare but severe adverse events associated with vaccinations. Given the widespread administration of COVID-19 vaccines, it is crucial to identify and understand such reactions to ensure timely diagnosis and management. Therefore, we review the existing cases of SCLS following COVID-19 vaccination. Our review highlights the need for heightened vigilance and further research into the mechanisms underlying vaccine-induced phenomena to improve patient outcomes and vaccine safety profiles.

COVID-19疫苗接种后不完全全身毛细血管渗漏综合征:一项基于病例的综述
尽管全身性水肿是药物或疫苗接种后罕见的不良事件,但我们报告了一例全身性水肿伴全身性炎症反应,临床类似于不完全性全身毛细血管渗漏综合征(SCLS),可能由COVID-19免疫引发。患者在接种疫苗后出现全身皮下水肿、血压下降、炎症生物标志物升高和低白蛋白血症,除疫苗接种外无其他明显原因。综合诊断评估未发现具体的根本原因。她成功地接受了糖皮质激素治疗。该病例强调了认识到与疫苗接种相关的罕见但严重的不良事件的重要性。鉴于COVID-19疫苗的广泛接种,识别和了解此类反应以确保及时诊断和管理至关重要。因此,我们回顾了COVID-19疫苗接种后发生的scs病例。我们的综述强调需要提高警惕,并进一步研究疫苗诱导现象的潜在机制,以改善患者预后和疫苗安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
17
审稿时长
6-12 weeks
期刊介绍: Central European Journal of Immunology is a English-language quarterly aimed mainly at immunologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信